The COVID-19 vaccines rush: participatory community engagement matters more than ever

Type Journal Article Author Rochelle Ann Burgess Author Richard H. Osborne Author Kenneth A. Yongabi Author Trisha Greenhalgh Author Deepti Gurdasani Author Gagandeep Kang Author Adegoke G. Falade Author Anna Odone Author Reinhard Busse Author Jose M. Martin-Moreno Author Stephen Reicher Author Martin McKee URL https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32642-8/abstract Publication The Lancet ISSN 0140-6736, 1474-547X Date 10/12/2020 Extra Publisher: Elsevier PMID: 33308484 Journal Abbr The Lancet DOI 10.1016/S0140-6736(20)32642-8 Library Catalog www.thelancet.com Language English Abstract The announcement of effective and safe vaccines for COVID-19 has been greeted with enthusiasm. Discussions continue about the ethical challenges of ensuring fair access to COVID-19 vaccines within and across countries, and which groups should be prioritised.1,2 There are concerns about equity in access to COVID-19 vaccines. Estimates as of Dec 2, 2020, suggest direct purchase agreements have allowed high-income countries to secure nearly 4 billion confirmed COVID-19 vaccine doses, compared with 2·7 billion secured by upper and lower middle-income countries. Short Title The COVID-19 vaccines rush